Lorna Cain , Louise J. Geneen , Michael Wiltshire , Catherine Kimber , Sue Proffitt , Josie Sandercock , Carolyn Dorée , Susan J. Brunskill , Lise J. Estcourt
{"title":"血小板的普遍辐照:辐照是否会影响输注血小板的质量、有效性和安全性?","authors":"Lorna Cain , Louise J. Geneen , Michael Wiltshire , Catherine Kimber , Sue Proffitt , Josie Sandercock , Carolyn Dorée , Susan J. Brunskill , Lise J. Estcourt","doi":"10.1016/j.tmrv.2024.150840","DOIUrl":null,"url":null,"abstract":"<div><div>We aimed to identify any detrimental effects on platelet quality and clinical effectiveness, of irradiated platelets compared to non-irradiated platelets for transfusion. The review was conducted in accordance with PRISMA guidelines. The protocol was prospectively registered on PROSPERO [CRD42023441930]. Our search identified 3002 references, of which we included 44 studies. Forty-one were <em>in vitro</em> only studies, two studies were in healthy volunteers, and one study reported clinical outcomes in thrombocytopenic patients. X-ray was used exclusively in three studies, and alongside gamma irradiation in one study. Two studies did not report the source of irradiation. The remaining 38 studies used gamma irradiation only. We assessed risk of bias (ROB) for studies reporting clinical and <em>in vivo</em> outcomes using ROB 2.0 (3 studies). We adapted a ROB tool designed for animal studies to assess ROB for the studies reporting <em>in vitro</em> outcomes (43 studies). We assessed the certainty of the evidence for the eight outcomes deemed most important to assess platelet quality and clinical effectiveness (where day 0 is the day of the blood draw).<ul><li><span>•</span><span><div>High certainty of a small decrease in pH (day 7) with irradiation: mean difference (MD) 0.04 lower (95% CI, −0.07 to −0.00).</div></span></li><li><span>•</span><span><div>Moderate certainty of an increase in P-selectin (day 5) with irradiation: MD 1.58 % higher (95% CI, 0.72-2.45).</div></span></li><li><span>•</span><span><div>Moderate certainty of no difference in supernatant glucose (days 5 and 7) and P-selectin (day 7).</div></span></li><li><span>•</span><span><div>Very low certainty of any difference in pH (day 5), post-transfusion bleeding risk (WHO 2+), and post-transfusion platelet survival time.</div></span></li></ul></div><div>Overall, gamma irradiation has little to no effect on most markers of platelet quality and effectiveness. Where there is evidence of detriment from irradiation, differences are small <em>in vitro</em>, and are unlikely to affect clinical outcomes following transfusion. However, the evidence base is limited. Only half the studies could be included in any analysis. There is very limited evidence for x-ray as a source of irradiation and, given the potential benefits of using x-ray over gamma irradiation (ease of use and safety requirements), we would welcome further research comparing x-ray to gamma, and x-ray to a non-irradiated control.</div></div>","PeriodicalId":56081,"journal":{"name":"Transfusion Medicine Reviews","volume":"38 4","pages":"Article 150840"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Universal irradiation of platelets: Does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?\",\"authors\":\"Lorna Cain , Louise J. Geneen , Michael Wiltshire , Catherine Kimber , Sue Proffitt , Josie Sandercock , Carolyn Dorée , Susan J. Brunskill , Lise J. Estcourt\",\"doi\":\"10.1016/j.tmrv.2024.150840\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>We aimed to identify any detrimental effects on platelet quality and clinical effectiveness, of irradiated platelets compared to non-irradiated platelets for transfusion. The review was conducted in accordance with PRISMA guidelines. The protocol was prospectively registered on PROSPERO [CRD42023441930]. Our search identified 3002 references, of which we included 44 studies. Forty-one were <em>in vitro</em> only studies, two studies were in healthy volunteers, and one study reported clinical outcomes in thrombocytopenic patients. X-ray was used exclusively in three studies, and alongside gamma irradiation in one study. Two studies did not report the source of irradiation. The remaining 38 studies used gamma irradiation only. We assessed risk of bias (ROB) for studies reporting clinical and <em>in vivo</em> outcomes using ROB 2.0 (3 studies). We adapted a ROB tool designed for animal studies to assess ROB for the studies reporting <em>in vitro</em> outcomes (43 studies). We assessed the certainty of the evidence for the eight outcomes deemed most important to assess platelet quality and clinical effectiveness (where day 0 is the day of the blood draw).<ul><li><span>•</span><span><div>High certainty of a small decrease in pH (day 7) with irradiation: mean difference (MD) 0.04 lower (95% CI, −0.07 to −0.00).</div></span></li><li><span>•</span><span><div>Moderate certainty of an increase in P-selectin (day 5) with irradiation: MD 1.58 % higher (95% CI, 0.72-2.45).</div></span></li><li><span>•</span><span><div>Moderate certainty of no difference in supernatant glucose (days 5 and 7) and P-selectin (day 7).</div></span></li><li><span>•</span><span><div>Very low certainty of any difference in pH (day 5), post-transfusion bleeding risk (WHO 2+), and post-transfusion platelet survival time.</div></span></li></ul></div><div>Overall, gamma irradiation has little to no effect on most markers of platelet quality and effectiveness. Where there is evidence of detriment from irradiation, differences are small <em>in vitro</em>, and are unlikely to affect clinical outcomes following transfusion. However, the evidence base is limited. Only half the studies could be included in any analysis. There is very limited evidence for x-ray as a source of irradiation and, given the potential benefits of using x-ray over gamma irradiation (ease of use and safety requirements), we would welcome further research comparing x-ray to gamma, and x-ray to a non-irradiated control.</div></div>\",\"PeriodicalId\":56081,\"journal\":{\"name\":\"Transfusion Medicine Reviews\",\"volume\":\"38 4\",\"pages\":\"Article 150840\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion Medicine Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0887796324000300\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887796324000300","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
我们旨在确定,与用于输血的未经过辐照的血小板相比,经过辐照的血小板对血小板质量和临床效果是否有任何不利影响。审查按照 PRISMA 指南进行。研究方案在 PROSPERO [CRD42023441930] 上进行了前瞻性注册。我们在检索中发现了 3002 篇参考文献,其中包括 44 项研究。其中 41 项仅为体外研究,2 项为健康志愿者研究,1 项研究报告了血小板减少患者的临床结果。三项研究只使用了 X 射线,一项研究同时使用了伽马射线照射。两项研究没有报告照射源。其余 38 项研究仅使用伽马射线照射。我们使用 ROB 2.0 评估了报告临床和体内结果的研究的偏倚风险(ROB)(3 项研究)。我们调整了专为动物研究设计的 ROB 工具,以评估报告体外结果的研究(43 项研究)的偏倚风险。我们对评估血小板质量和临床疗效最重要的八项结果(第 0 天为抽血当天)的证据确定性进行了评估。总体而言,伽马辐照对大多数血小板质量和有效性指标几乎没有影响。如果有证据表明辐照会对血小板质量和有效性产生不利影响,那么这种影响在体外是微小的,不太可能影响输血后的临床结果。然而,证据基础是有限的。只有一半的研究可纳入任何分析。X 射线作为辐照源的证据非常有限,考虑到 X 射线辐照比伽马射线辐照的潜在优势(使用方便和安全要求),我们欢迎进一步研究 X 射线与伽马射线辐照的比较,以及 X 射线与非辐照对照的比较。
Universal irradiation of platelets: Does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
We aimed to identify any detrimental effects on platelet quality and clinical effectiveness, of irradiated platelets compared to non-irradiated platelets for transfusion. The review was conducted in accordance with PRISMA guidelines. The protocol was prospectively registered on PROSPERO [CRD42023441930]. Our search identified 3002 references, of which we included 44 studies. Forty-one were in vitro only studies, two studies were in healthy volunteers, and one study reported clinical outcomes in thrombocytopenic patients. X-ray was used exclusively in three studies, and alongside gamma irradiation in one study. Two studies did not report the source of irradiation. The remaining 38 studies used gamma irradiation only. We assessed risk of bias (ROB) for studies reporting clinical and in vivo outcomes using ROB 2.0 (3 studies). We adapted a ROB tool designed for animal studies to assess ROB for the studies reporting in vitro outcomes (43 studies). We assessed the certainty of the evidence for the eight outcomes deemed most important to assess platelet quality and clinical effectiveness (where day 0 is the day of the blood draw).
•
High certainty of a small decrease in pH (day 7) with irradiation: mean difference (MD) 0.04 lower (95% CI, −0.07 to −0.00).
•
Moderate certainty of an increase in P-selectin (day 5) with irradiation: MD 1.58 % higher (95% CI, 0.72-2.45).
•
Moderate certainty of no difference in supernatant glucose (days 5 and 7) and P-selectin (day 7).
•
Very low certainty of any difference in pH (day 5), post-transfusion bleeding risk (WHO 2+), and post-transfusion platelet survival time.
Overall, gamma irradiation has little to no effect on most markers of platelet quality and effectiveness. Where there is evidence of detriment from irradiation, differences are small in vitro, and are unlikely to affect clinical outcomes following transfusion. However, the evidence base is limited. Only half the studies could be included in any analysis. There is very limited evidence for x-ray as a source of irradiation and, given the potential benefits of using x-ray over gamma irradiation (ease of use and safety requirements), we would welcome further research comparing x-ray to gamma, and x-ray to a non-irradiated control.
期刊介绍:
Transfusion Medicine Reviews provides an international forum in English for the publication of scholarly work devoted to the various sub-disciplines that comprise Transfusion Medicine including hemostasis and thrombosis and cellular therapies. The scope of the journal encompasses basic science, practical aspects, laboratory developments, clinical indications, and adverse effects.